Bristol Investment Partners, LLC Sends Letter To Jaguar Mining Board Of Directors

Intends to Withhold 100% of Bristol's Share Votes Against Reelection of Gary German, Gil Clausen and John Andrews to the Board at Jaguar's Upcoming Annual General Meeting

DARIEN, Conn., June 13, 2012 /CNW/ - Bristol Investment Partners, LLC (together with its affiliates, "Bristol"), the largest shareholder of Jaguar Mining Inc. ("Jaguar" or the "Company") (JAG:TSX/NYSE) with current ownership of approximately 8.6% of the outstanding shares, today announced that it has delivered a letter to Jaguar's Board of Directors (the "Board") to inform the Board of Bristol's intention to withhold 100% of its share votes against the reelection of directors Gary German, Gil Clausen and John Andrews to the Board at Jaguar's Annual General Meeting scheduled to be held on June 29, 2012 (the "AGM"). In the letter, Bristol outlines in full detail six primary reasons for its decision to withhold votes for these three Jaguar directors at the upcoming AGM.

The full text of Bristol's letter to the Board can be viewed at the following link:

This is not a solicitation of authority to vote your proxy. Bristol is only informing other Jaguar securityholders of how it intends to vote and the reasons for that decision. Bristol is not seeking the power to act as a proxyholder for any securityholder of Jaguar and nothing in this press release should be regarded as a solicitation or a request for a proxy.

Investor contact:
Anna Povinelli
Chief Compliance Officer
Bristol Investment Partners, LLC
(203) 656-2432

SOURCE Bristol Investment Partners, LLC

Profil de l'entreprise

Bristol Investment Partners, LLC

Renseignements sur cet organisme


Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .


Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.


Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.